Japan, March 5 -- TAISHO PHARMACEUTICAL CO LTD has got intellectual property rights for 'COMPOSITION.' Other related details are as follows:
Application Number: JP,2022-022544
Category (FI): A61P25/28,A61P9/00,A61Q7/00,A61Q19/08,A61P43/00,121,A61K31/185,A61P17/00,A61K36/65,A61K8/9789,A61K8/46
Stage: PROBLEM TO BE SOLVED: To provide a composition having excellent action of inhibiting a decrease in MITOL and or promoting its production.MEANS FOR SOLVING THE PROBLEM: A composition contains moutan bark and taurine. Combinational use of moutan bark and taurine can markedly enhance the action of moutan bark to promote MITOL production.SELECTED DRAWING: Figure 2 (Grant)
Filing Date: Feb. 17, 2022
Publication Date: Sept. 15, 2022
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
